Skip to content

AstraZeneca PLC ADR Price, Chart & Factor Analysis

Free Data & Analytics Access

Latest earnings: April 29, 2026 results vs estimates

AstraZeneca PLC ADR · E.AZN.NASDAQ · United States
Use symbol E.AZN.NASDAQ in our API & Excel add-in to retrieve this data ↓
174.40
(+0.03%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 75%
Bubble Risk LOW
Realised Volatility (20D) 26.21%

AstraZeneca PLC ADR Forecast

AstraZeneca PLC ADR short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 26.2% a year, a typical one-standard-deviation range is 167.96–180.84 over a week, 161.20–187.60 over a month and 128.68–220.12 over a year. (Signals as of 1 Nov 2026.)

AstraZeneca PLC ADR Price Chart

MacroFinance.ai

AstraZeneca PLC ADR Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
AstraZeneca PLC ADR
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
AstraZeneca PLC ADR
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
AstraZeneca PLC ADR
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for AstraZeneca PLC ADR, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on AstraZeneca PLC ADR

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

AstraZeneca PLC ADR Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to AstraZeneca PLC ADR; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How AstraZeneca PLC ADR’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how AstraZeneca PLC ADR behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About AstraZeneca PLC ADR (United States)

AstraZeneca PLC ADR is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on AstraZeneca PLC

Frequently asked questions

What is AstraZeneca PLC ADR?
AstraZeneca PLC ADR is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest AstraZeneca PLC ADR price?
The latest close is 174.4 (1 Nov 2026), +0.03% on the day. The price at the top of the page refreshes during the trading day.
Is AstraZeneca PLC ADR in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (7 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is AstraZeneca PLC ADR?
20-day realised volatility is 26.2% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 7.6% over a month and 3.7% over a week.
What factors affect AstraZeneca PLC ADR?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to AstraZeneca PLC ADR, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade AstraZeneca PLC ADR?
58 backtested tactical asset allocation strategies trade AstraZeneca PLC ADR through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are AstraZeneca PLC ADR returns analysed?
The Statistical Distribution of Returns section shows the distribution of AstraZeneca PLC ADR daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free AstraZeneca PLC ADR historical data?
In the Free historical data section of this page: the last 10 years of AstraZeneca PLC ADR daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free AstraZeneca PLC ADR historical data (last 10 years)

Browse or instantly download the last 10 years of AstraZeneca PLC ADR daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.AZN.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20174.35
2026-11-19175.41
2026-11-18178.76
2026-11-17182.27
2026-11-16184.02
2026-11-13184.45
2026-11-12184.38
2026-11-11185.48
2026-11-10186.76
2026-11-09189.39
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies for rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, USA, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of oral candidates; Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates; and Carterra, Inc. to advances lab-in-the-loop drug discovery through new scientific research collaboration. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is based in Cambridge, the United Kingdom.